These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1587429)

  • 1. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
    Lok AS; Wu PC; Lai CL; Lau JY; Leung EK; Wong LS; Ma OC; Lauder IJ; Ng CP; Chung HT
    Gastroenterology; 1992 Jun; 102(6):2091-7. PubMed ID: 1587429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-interferon treatment in Chinese patients with chronic hepatitis B.
    Lok AS; Lai CL; Wu PC; Lau JY; Leung EK; Wong LS; Fung YL
    J Hepatol; 1990; 11 Suppl 1():S121-5. PubMed ID: 2079568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
    Perez V; Tanno H; Villamil F; Fay O
    J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
    Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
    J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.
    Fevery J; Elewaut A; Michielsen P; Nevens F; Van Eyken P; Adler M; Desmet V
    J Hepatol; 1990; 11 Suppl 1():S108-12. PubMed ID: 2079566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
    Perez V; Findor J; Tanno H; Sordá J
    Gut; 1993; 34(2 Suppl):S91-4. PubMed ID: 8314497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial.
    Utili R; Sagnelli E; Giusti G; Ruggiero G; Piccinino F; Galanti B; Adinolfi LE; Aprea L; Cesaro G; Digilio L
    Arch Virol Suppl; 1992; 4():277-80. PubMed ID: 1450701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
    Realdi G; Fattovich G; Pastore G; Caredda F; Noventa F; Santantonio T; Moroni M; Criscuolo D; Maladorno D; Rugge M
    J Hepatol; 1990; 11 Suppl 1():S129-32. PubMed ID: 2079570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.
    Chan HL; Leung NW; Hui AY; Wong VW; Liew CT; Chim AM; Chan FK; Hung LC; Lee YT; Tam JS; Lam CW; Sung JJ
    Ann Intern Med; 2005 Feb; 142(4):240-50. PubMed ID: 15710957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.
    Sarin SK; Guptan RC; Thakur V; Malhotra S; Malhotra V; Banerjee K; Khandekar P
    J Hepatol; 1996 Apr; 24(4):391-6. PubMed ID: 8738724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
    Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.